Immunitybio Inc (IBRX)

NASDAQ
14.93
-0.26(-1.71%)
After Hours
14.94
+0.01(+0.07%)
- Real-time Data
  • Volume:
    1,145,651
  • Bid/Ask:
    14.94/15.50
  • Day's Range:
    14.81 - 15.40

IBRX Overview

Prev. Close
14.93
Day's Range
14.81-15.4
Revenue
230K
Open
15.2
52 wk Range
6.03-45.42
EPS
-0.91
Volume
1,145,651
Market Cap
5.73B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,219,151
P/E Ratio
-
Beta
2.11
1-Year Change
117.01%
Shares Outstanding
383,905,840
Next Earnings Date
Aug 09, 2021
What is your sentiment on Immunitybio Inc?
or
Market is currently closed. Voting is open during market hours.

Immunitybio Inc News

Immunitybio Inc Analysis

  • 5 Stocks With Strong Upward Momentum

    1. Brainstorm Cell TherapeuticsBrainstorm Cell Therapeutics (NASDAQ:BCLI) on Wednesday was up a small fraction, gaining 35 cents, or 2.8%, to 12.83, with an early morning high of...

  • 6 Stocks That Could Shoot Higher

    1. Akebia TherapeuticsAkebia Therapeautics (NASDAQ:AKBA) actually broke out on Tuesday from a 2-month consolidation, popping 88 cents, or 7%, closing at the session high of the...

  • 7 Stocks That Could Jump Higher

    1. The Boeing CompanyBoeing (NYSE:BA), on the 737 MAX testing on Monday, popped out of a wedge and jumped 24.48, or 14.4%, to 194.49, just a penny off the session high at 194.50,...

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellSellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellBuy

Immunitybio Inc Company Profile

Immunitybio Inc Company Profile

Employees
475

Immunitybio, Inc., formerly NantKwest, Inc., is a late-clinical-stage immunotherapy company developing therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The Company’s immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T-cell) immune systems to create long-term immunological memory. The Company is engaged in developing molecular and product platforms based on three key modalities: activating NK and T cells using antibody cytokine fusion proteins, activating tumoricidal macrophages using low-dose synthetic immunomodulators, and generating memory T cells using vaccine candidates developed with second-generation adenovirus (hAd5) technology. It is also developing therapies, including vaccines, for the prevention and treatment of human immunodeficiency virus (HIV), influenza, and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with its human adenovirus (hAd5) vaccine technologies.

Read More
  • looks like a buy
    0
    • just buy
      0
      • Now what's up here, why is it falling so much?
        0
        • In March, NK may publish readout of  Phase 1 trials done in the US. If data is really good, I expect NK to receive funding from Opn Warp Spee / other Fed agencies to pursue clinical trials in Phase 2. This could be a major trigger and could more than double the share price.....watch out.
          0
          • interesting, thx
            0
        • TIME 2 BUY
          1
          • NK will merge with InmunityBio pretty soon, I read NK stocks will be a 18% aprox. of the new resulting company, isn't that a kind of dilution for our NK investment?
            0
            • 28% actually
              0
            • Nope. The new resulting company will be almost 4 times bigger, that's why nk goes from owning 100% of nk to owning just 28% of the resulting company. You can be the owner of your piece of pizza or the owner of a portion of the whole pizza.
              1
          • What a nice couple months for NK, keep it up Patrick!
            0
            • if u followed my recommendation on NK congrats.... now time to RDHL.. thank me in a month 3x opportunity
              0
              • Holding 40k shares average low 6.
                0
                • Good for you, love hearing stories like this! What is your target sales price? Looks like this could shoot to the moon....
                  0
              • time to add boyz
                0
                • nice flag
                  0
                  • Target 20 today.
                    0
                    • 10 bagger at least... only 1 candidate needs to work
                      0
                      • very good job Sam. do you have other to suggest?
                        0
                      • Pierlu Vasister company nh qbout to move
                        0
                    • got in a little late 15 @16.04
                      0
                      • Gonna be a nice day for those that have held on!
                        0
                        • I'm all in from 7.5.... very longterm hold, this could be a 20 bagger or 30 bagger
                          0
                          • Finally, the only vaccine that will activate T CELLs is beginning trials this month!!  Bet the FARM!! https://seekingalpha.com/pr/18044337-fda-authorizes-phase-1-trial-of-immunitybio-s-novel-covidminus-19-vaccine-candidate-had5-dual
                            0
                            • https://finance.yahoo.com/news/fda-authorizes-phase-1-trial-100000557.html
                              0
                              • Nice run here, anyone predicting where a good point to sell is or go LONG?
                                0
                                • unless you understand what you're buying, you will not have the conviction to stick to your investment... this is one of the most played stocks by day traders... pumping, dumping, runs, overnight, etc.. you have to be ready to see ur money down big time... so read first to be comfortable... otherwise just be another day tradrr.. few cents here, few cents there
                                  0
                                • Finally, the only vaccine that will activate T CELLs is beginning trials this month!!  Bet the FARM!! https://seekingalpha.com/pr/18044337-fda-authorizes-phase-1-trial-of-immunitybio-s-novel-covidminus-19-vaccine-candidate-had5-dual
                                  0
                              • those that don't understand what a company does, they get out on a downturn... and those that understand, buy more!
                                0
                                • Going up against COVID
                                  0
                                  • https://www.fool.com/investing/2020/06/22/heres-why-nantkwest-rocketed-higher-today.aspx Early Birds!  Get your worm here!
                                    0
                                    • on the next news, this is doubling or tripling.... way too many good candidate drugs... the likelihood that none of the candidates move forward is so small.. that I'm betting the house on this
                                      1
                                      • Did you really take out a loan to finance this rocket ? hahaha
                                        0
                                    • As always it will go back down. It will end up around 6 in 2 weeks. .
                                      0
                                      • buy in at 3.55
                                        0
                                        • Congrats
                                          0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.